SHAB published 26 May 2025 · legal date 30 Apr 2025
Capital increase
Not assessed
Paid in cash
Nominal capital
100’000 → 112’000
Shares
10’000’000 → 11’200’000
New shares, % of post-step shares
10.7% (1’200’000 new)
Augmentation ordinaire du capital-actions porté de CHF 100'000 à CHF 112'000 par l'émission de 1'200'000 actions de CHF 0.01, nominatives. Capital-actions: CHF 112'000, entièrement libéré, divisé en 11'200'000 actions de CHF 0.01, nominatives.
SHAB published 3 Feb 2026 · legal date 18 Dec 2025
Capital increase
●●○Likely financing
Paid in cash
Nominal capital
112’000 → 117’600
Shares
11’200’000 → 11’760’000
New shares, % of post-step shares
4.8% (560’000 new)
Augmentation ordinaire du capital-actions porté de CHF 112'000 à CHF 117'600 par l'émission de 560'000 actions de CHF 0.01. Capital-actions: CHF 117'600, entièrement libéré, divisé en 11'760'000 actions de CHF 0.01, nominatives.
From the SHAB entry · French original, person names removed · not an official copy · full entry ↗
The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
The company was founded less than six years before this capital increase.+0.5
The company's purpose describes technology or life-sciences development.+0.5
Classifier score 0.62 · likely-financing threshold 0.60 · not a calibrated probability